AtriCure, Inc. (ATRC)
USD 30.25
(-3.97%)
USD 30.25
(-3.97%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 74.49 Million USD | 7.84% |
| 2022 | 69.07 Million USD | -8.69% |
| 2021 | 75.64 Million USD | 2.22% |
| 2020 | 74 Million USD | -3.17% |
| 2019 | 76.42 Million USD | 45.68% |
| 2018 | 52.46 Million USD | 40.18% |
| 2017 | 37.42 Million USD | -3.78% |
| 2016 | 38.89 Million USD | 174.67% |
| 2015 | 14.16 Million USD | 249.2% |
| 2014 | 4.05 Million USD | -37.13% |
| 2013 | 6.45 Million USD | -23.54% |
| 2012 | 8.43 Million USD | 30.41% |
| 2011 | 6.46 Million USD | 126.57% |
| 2010 | 2.85 Million USD | 6.94% |
| 2009 | 2.66 Million USD | -56.02% |
| 2008 | 6.07 Million USD | 448.08% |
| 2007 | 1.1 Million USD | 2.18% |
| 2006 | 1.08 Million USD | -26.85% |
| 2005 | 1.48 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 75.31 Million USD | -0.06% |
| 2024 Q1 | 75.36 Million USD | 1.17% |
| 2024 Q3 | 61.86 Million USD | 2.41% |
| 2023 Q3 | 74.37 Million USD | -0.61% |
| 2023 Q4 | 74.49 Million USD | 0.16% |
| 2023 FY | 74.49 Million USD | 7.84% |
| 2023 Q1 | 75.22 Million USD | 8.9% |
| 2023 Q2 | 74.83 Million USD | -0.52% |
| 2022 Q4 | 69.07 Million USD | -7.67% |
| 2022 Q1 | 75.31 Million USD | -0.43% |
| 2022 Q3 | 74.81 Million USD | -0.21% |
| 2022 FY | 69.07 Million USD | -8.69% |
| 2022 Q2 | 74.96 Million USD | -0.46% |
| 2021 FY | 75.64 Million USD | 2.22% |
| 2021 Q1 | 73.57 Million USD | -0.58% |
| 2021 Q2 | 74.53 Million USD | 1.3% |
| 2021 Q3 | 72.84 Million USD | -2.27% |
| 2021 Q4 | 75.64 Million USD | 3.85% |
| 2020 Q2 | 74.81 Million USD | -1.61% |
| 2020 FY | 74 Million USD | -3.17% |
| 2020 Q1 | 76.04 Million USD | -0.5% |
| 2020 Q4 | 74 Million USD | -0.74% |
| 2020 Q3 | 74.55 Million USD | -0.35% |
| 2019 Q2 | 53.82 Million USD | -0.54% |
| 2019 FY | 76.42 Million USD | 45.68% |
| 2019 Q1 | 54.11 Million USD | 3.16% |
| 2019 Q4 | 76.42 Million USD | 0.01% |
| 2019 Q3 | 76.41 Million USD | 41.97% |
| 2018 Q3 | 52.44 Million USD | -0.06% |
| 2018 FY | 52.46 Million USD | 40.18% |
| 2018 Q4 | 52.46 Million USD | 0.02% |
| 2018 Q2 | 52.48 Million USD | -0.06% |
| 2018 Q1 | 52.51 Million USD | 40.33% |
| 2017 Q3 | 38.69 Million USD | -0.18% |
| 2017 Q4 | 37.42 Million USD | -3.28% |
| 2017 Q1 | 38.82 Million USD | -0.17% |
| 2017 FY | 37.42 Million USD | -3.78% |
| 2017 Q2 | 38.76 Million USD | -0.17% |
| 2016 Q4 | 38.89 Million USD | -0.12% |
| 2016 Q3 | 38.93 Million USD | -0.02% |
| 2016 Q2 | 38.94 Million USD | 177.12% |
| 2016 Q1 | 14.05 Million USD | -0.75% |
| 2016 FY | 38.89 Million USD | 174.67% |
| 2015 Q4 | 14.16 Million USD | 3.82% |
| 2015 Q1 | 6.07 Million USD | 49.82% |
| 2015 Q2 | 9.3 Million USD | 53.17% |
| 2015 Q3 | 13.63 Million USD | 46.58% |
| 2015 FY | 14.16 Million USD | 249.2% |
| 2014 Q3 | 2.59 Million USD | 2349.06% |
| 2014 Q1 | 107 Thousand USD | -98.34% |
| 2014 FY | 4.05 Million USD | -37.13% |
| 2014 Q2 | 106 Thousand USD | -0.93% |
| 2014 Q4 | 4.05 Million USD | 56.2% |
| 2013 Q2 | 7.42 Million USD | -6.39% |
| 2013 Q4 | 6.45 Million USD | -7.31% |
| 2013 FY | 6.45 Million USD | -23.54% |
| 2013 Q1 | 7.92 Million USD | -6.01% |
| 2013 Q3 | 6.95 Million USD | -6.24% |
| 2012 Q4 | 8.43 Million USD | -5.21% |
| 2012 Q2 | 9.4 Million USD | -5.16% |
| 2012 Q1 | 9.91 Million USD | 53.3% |
| 2012 FY | 8.43 Million USD | 30.41% |
| 2012 Q3 | 8.9 Million USD | -5.37% |
| 2011 FY | 6.46 Million USD | 126.57% |
| 2011 Q4 | 6.46 Million USD | -5.16% |
| 2011 Q3 | 6.82 Million USD | -5.32% |
| 2011 Q2 | 7.2 Million USD | -5.05% |
| 2011 Q1 | 7.58 Million USD | 165.74% |
| 2010 Q1 | 4.39 Million USD | -10.27% |
| 2010 FY | 2.85 Million USD | 6.94% |
| 2010 Q4 | 2.85 Million USD | -15.38% |
| 2010 Q3 | 3.37 Million USD | -13.2% |
| 2010 Q2 | 3.88 Million USD | -11.55% |
| 2009 Q3 | 5.29 Million USD | -8.4% |
| 2009 FY | 2.66 Million USD | -56.02% |
| 2009 Q1 | 62.34 Thousand USD | -98.97% |
| 2009 Q2 | 5.78 Million USD | 9175.39% |
| 2009 Q4 | 4.89 Million USD | -7.55% |
| 2008 Q2 | 571.38 Thousand USD | -16.8% |
| 2008 FY | 6.07 Million USD | 448.08% |
| 2008 Q4 | 6.07 Million USD | -0.13% |
| 2008 Q3 | 6.07 Million USD | 963.85% |
| 2008 Q1 | 686.75 Thousand USD | -38.0% |
| 2007 Q4 | 1.1 Million USD | 38.93% |
| 2007 Q2 | 892.2 Thousand USD | -9.79% |
| 2007 Q1 | 989.06 Thousand USD | -8.76% |
| 2007 FY | 1.1 Million USD | 2.18% |
| 2007 Q3 | 797.26 Thousand USD | -10.64% |
| 2006 FY | 1.08 Million USD | -26.85% |
| 2006 Q1 | 1.36 Million USD | -8.04% |
| 2006 Q3 | 1.17 Million USD | -7.32% |
| 2006 Q2 | 1.27 Million USD | -6.7% |
| 2006 Q4 | 1.08 Million USD | -8.01% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | 1.48 Million USD | -5.57% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | 1.56 Million USD | 0.0% |
| 2005 FY | 1.48 Million USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 13.082% |
| AngioDynamics, Inc. | 5.91 Million USD | -1159.621% |
| Avinger, Inc. | 15.39 Million USD | -383.884% |
| Azenta, Inc. | 60.43 Million USD | -23.261% |
| BioLife Solutions, Inc. | 42.69 Million USD | -74.496% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 97.1% |
| Daxor Corporation | 755.65 Thousand USD | -9758.15% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -939.258% |
| Femasys Inc. | 6.7 Million USD | -1011.704% |
| GlucoTrack, Inc. | 196 Thousand USD | -37907.143% |
| Harvard Bioscience, Inc. | 42.77 Million USD | -74.161% |
| Hologic, Inc. | 2.53 Billion USD | 97.061% |
| ICU Medical, Inc. | 1.7 Billion USD | 95.63% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 17.045% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -1575.86% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | -290.123% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 92.32% |
| Microbot Medical Inc. | 231 Thousand USD | -32148.485% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -916.132% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 91.643% |
| Nephros, Inc. | 1.83 Million USD | -3957.407% |
| NovoCure Limited | 596.24 Million USD | 87.506% |
| NEXGEL, Inc. | 2.79 Million USD | -2562.402% |
| NEXGEL, Inc. | 2.79 Million USD | -2562.402% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 1.055% |
| OraSure Technologies, Inc. | 13.5 Million USD | -451.644% |
| Pro-Dex, Inc. | 13.54 Million USD | -449.893% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -714.676% |
| Predictive Oncology Inc. | 2.85 Million USD | -2507.59% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -2069.016% |
| QuidelOrtho Corporation | 2.61 Billion USD | 97.15% |
| Repligen Corporation | 711.8 Million USD | 89.534% |
| Sanara MedTech Inc. | 11.79 Million USD | -531.727% |
| STAAR Surgical Company | 35.83 Million USD | -107.886% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -21681.871% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 96.76% |
| Jin Medical International Ltd. | 4.11 Million USD | -1711.184% |